Preliminary Study of the Distinctive Mechanism of Shenqi Compound in Treating Rats with Type 2 Diabetes Mellitus by Comparing with Metformin.
Curr Vasc Pharmacol
; 21(2): 120-127, 2023.
Article
in En
| MEDLINE
| ID: mdl-36752289
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drugs, Chinese Herbal
/
Diabetes Mellitus, Type 2
/
Metformin
Type of study:
Diagnostic_studies
Limits:
Animals
Language:
En
Journal:
Curr Vasc Pharmacol
Journal subject:
ANGIOLOGIA
/
FARMACOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: